FRE Insider Trading

Insider Ownership Percentage: 50.38%
Insider Buying (Last 12 Months): A$28,500.00
Insider Selling (Last 12 Months): A$0.00

Firebrick Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Firebrick Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Firebrick Pharma Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 11/28/2022 10:10 AM ET

This chart shows the closing price history over time for FRE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Firebrick Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/27/2024Peter MolloyInsiderBuy500,000A$0.06A$28,500.00
6/20/2023Stephen GoodallInsiderIssued530,000A$0.15A$79,500.00
11/24/2022Richard TreagusInsiderIssued100,000A$0.17A$17,300.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Firebrick Pharma (ASX:FRE)

0.66% of Firebrick Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Firebrick Pharma Limited engages in the development and partnering of broad-spectrum antimicrobial spray for the treatment of common cold under the Nasodine name in Australia. The company was incorporated in 2012 and is based in Melbourne, Australia.
Read More on Firebrick Pharma

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.67

Who are the company insiders with the largest holdings of Firebrick Pharma?

Firebrick Pharma's top insider investors include:
  1. Peter Molloy (Insider)
  2. Richard Treagus (Insider)
  3. Stephen Goodall (Insider)
Learn More about top insider investors at Firebrick Pharma.